MiNK Therapeutics Inc

XNAS:INKT  
10.28
-0.67 (-6.12%)
5:03:47 PM EDT: $10.40 +0.12 (+1.17%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

MiNK Therapeutics Inc Stock, XNAS:INKT

149 5th Avenue, Suite 500, New York, New York 10010
United States of America
Phone: +1.212.994.8250
Number of Employees: 23
http://www.minktherapeutics.com

Description

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.